Download our 340B Program White Paper on Referrals for Consultation, Compliance and Eligibility.

A Primer for 340B Professionals


This white paper provides an overview of the U.S. Department of Health and Human Services (HHS) Health Resources and Services Administration's (HRSA) 340B Drug Discount Pricing Program with a particular focus on aspects of legislation and regulation that impact patient definition and referral prescriptions.

In addition to a brief overview of the program's origin and history, this paper further provides an in-depth analysis of patient definition by describing:

  • HHS and Apexus positions with respect to patient and provider eligibility.
  • Current and historical guidelines on patient definition with an emphasis on referral prescriptions.
  • An exclusive data analysis from eight 340B CE contract pharmacies and vendor partners revealing overall referral prescription capture rate at 2% and specialty capture nearly absent.
  • Operational and technical challenges involved in capturing referral prescriptions in a manner that satisfies HRSA audits.
  • How par8o 340B Referral Capture solves current challenges.